First Capital Advisors »

Alnylam Pharmaceuticals shares owned by First Capital Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by First Capital Advisors from 13F filings

Historical chart of First Capital Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by First Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by First Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $80k 423 189.94

More positions owned by First Capital Advisors

Strategy Day Hagan Ned (SSUS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Spdr Gold Tr Gold Shs (GLD)
J P Morgan Exchange Traded F Jpmorgan Diver (JPUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Legg Mason Etf Invt Franklin Intl Lw (LVHI)
Innovator Etfs Tr Us Eqty Pwr Buf (PMAR)
Invesco Exchange Traded Fd T S&p 500 Garp Etf (SPGP)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Microsoft Corporation (MSFT)
Ishares Tr Mbs Etf (MBB)
Goldman Sachs Etf Tr Activebeta Eme (GEM)

View all positions for First Capital Advisors

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
FMR
BlackRock
Wellington Management Company
Baillie Gifford & Co
T. Rowe Price Associates
Dodge & Cox
T. Rowe Price Investment Management
Geode Capital Management
Jpmorgan Chase & Co
American Century Companies
Susquehanna International
venBio Select Advisor
Pictet Asset Management Holding SA
Legal & General Group

View all funds holding Alnylam Pharmaceuticals